Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης

  • Home
  • Greece
  • Athens
  • Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης

Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης, Nonprofit Organization, 127 Λεωφόρος Βασιλίσσης Σοφίας, Athens.

10/04/2026
✅Με επιτυχία ολοκληρώθηκε η 43η Ημερίδα της ΕΛΕΡΓΑ, με θέμα "Κλινική Εργοσπιρομετρία, Άσκηση και Αποκατάσταση". Ιδιαίτερ...
16/03/2026

✅Με επιτυχία ολοκληρώθηκε η 43η Ημερίδα της ΕΛΕΡΓΑ, με θέμα "Κλινική Εργοσπιρομετρία, Άσκηση και Αποκατάσταση". Ιδιαίτερη σημασία δόθηκε στο κομμάτι της διαδραστικότητας και πρακτικής εφαρμογής των μεθόδων αποκατάστασης σε ασθενείς.

📌Θερμές ευχαριστίες προς τα αξιότιμα Προεδρεία κάθε ενότητας, τους εξαίρετους ομιλητές της Ημερίδας, και φυσικά στους χορηγούς και το ακροατήριο, που όλοι συνδυαστικά, συνέβαλαν στην διεξαγωγή μιας άρτιας επιστημονικής συνάντησης με ουσιαστικό αποτύπωμα. Ευχή και δέσμευση όλων, η ΕΛΕΡΓΑ να συνεχίσει και να αναβαθμίζει τη συμβολή της στον τομέα της Αποκατάστασης.

📌43η Ημερίδα ΕΛΕΡΓΑΚλινική Εργοσπιρομετρία & Αποκατάσταση
14/03/2026

📌43η Ημερίδα ΕΛΕΡΓΑ
Κλινική Εργοσπιρομετρία & Αποκατάσταση

43η Ημερίδα ΕΛΕΡΓΑ - Σάββατο 14 Μαρτίου 2026📌Ελληνικό Ινστιτούτο Παστέρ (Λ. Βασιλίσσης Σοφίας 127-Αθήνα)🔗Πληροφορίες-Πρό...
06/03/2026

43η Ημερίδα ΕΛΕΡΓΑ - Σάββατο 14 Μαρτίου 2026
📌Ελληνικό Ινστιτούτο Παστέρ (Λ. Βασιλίσσης Σοφίας 127-Αθήνα)

🔗Πληροφορίες-Πρόγραμμα
https://elerga.org/ #
https://elerga.org/elerga_cms/uploads/file/elerga-program-2026-c.pdf

30/07/2025
AbstractBackgroundPulmonary rehabilitation (PR) is a beneficial intervention for people with interstitial lung disease (...
12/06/2025

Abstract

Background
Pulmonary rehabilitation (PR) is a beneficial intervention for people with interstitial lung disease (ILD); however, the effect of PR on survival is unclear. This study compared the survival outcomes in people with ILD who were allocated to PR vs those who were allocated to control in 2 published randomized controlled trials.

Research Question
Does participation in PR impact survival among people with ILD?

Study Design and Methods
The combined data from the 2 previous randomized controlled trials of PR in ILD were included. Time from start of PR until date of death, lung transplantation, or censoring was calculated. Kaplan-Meir and Cox proportional hazard regression analysis were used to assess the impact of PR on survival. Baseline variables of age at time of PR, s*x, FVC, 6-minute walk distance, exertional nadir oxyhemoglobin desaturation, and diagnosis of idiopathic pulmonary fibrosis were included as covariates.

Results
Of the 182 participants with ILD (idiopathic pulmonary fibrosis: n = 87; male: n = 109; mean age ± SD, 69 ± 10; FVC % predicted ± SD, 76 ± 19; carbon monoxide transfer factor % predicted ± SD, 48 ± 16), death occurred in 62%, 6% were transplanted, 20% were alive, and 12% were lost to follow-up. Median survival for those who completed PR was 6.1 years (95% CI, 4.4-7.9) compared with 4.7 years (95% CI, 3.4-6.0) for those in the control group; however, this was not significantly different (log rank P = .70). After adjusting for baseline variables at 5 years, completion of PR was associated with a 44% lower risk of mortality (hazard ratio, 0.56; 95% CI, 0.36-0.88; P = .01). At 10 years, no difference in survival was observed between the PR and control group.

Interpretation
Participation in PR among people with ILD may impact survival at 5 years. Along with clinical improvements after PR, the potential for a survival benefit further strengthens the importance of PR in the standard care of people with ILD.

https://journal.chestnet.org/article/S0012-3692(25)00005-4/abstract

29/04/2025

ABSTRACT
Background
Pulmonary arterial hypertension (PAH) is a complex cardiopulmonary disease associated with exertional dyspnea and impaired health-related quality of life (HRQOL) despite medical therapy. Pulmonary rehabilitation (PR), a supervised exercise program for patients with chronic lung disease, improves symptoms, HRQOL and exercise capacity. Despite these benefits, there is a paucity of data regarding PR in PAH.
Research Question
What is the frequency of PR referrals among patients with PAH and what factors are associated with PR referrals?
Study design and Methods
We performed a retrospective cohort study of adults with PAH enrolled in the Pulmonary Hypertension Association Registry (PHAR). Patients referred to PR by the time of the second follow-up visit were compared to patients never referred to PR.
Results
PR referral rates were 17.0%, 26.6% and 32.3% at the first, second and third follow-up visits, respectively. Patients referred to PR were older (58.3 ± 15.3 vs. 55.2 ± 15.6, p

AbstractRationale: Understanding virtual pulmonary rehabilitation (VPR) in the U.S. would inform clinicians and patients...
11/03/2025

Abstract
Rationale:
Understanding virtual pulmonary rehabilitation (VPR) in the U.S. would inform clinicians and patients, guide healthcare systems to ensure quality and safety, and inform payers on reimbursement issues.

Objective:
To characterize U.S. VPR programs.

Methods:
A 40-question online survey was developed by the American Thoracic Society PR Reimbursement Working Group to assess delivery methods, program content, and outcome assessments. U.S. VPR programs were identified from the Livebetter database, the internet, and scientific publications. Veterans Affairs (VA) sites were identified from an email sent to medical service chiefs asking whether their site offered VPR. The survey was sent to 53 programs using SurveyMonkey. Responses were summarized as percentages of available data. The 2010 Rural-Urban Commuting Area Codes characterized rurality.

Results:
Twenty-five sites currently and 5 previously offered VPR; 23 were offered by an outpatient hospital department (7 non-VA, 16 VA), 5 were commercial, 1 physician office-based, and 1 independent. Eighty-four percent (16/19) of VPR programs offered by outpatient hospital departments concomitantly provided in-person PR, while 25% (1/4) of commercial sites did. Delivery method was ‘live’ 2-way videoconferencing for 88% (22/25) of sites; 47% (7/15) VA sites was also telephone-based, and 60% (3/5) commercial entities also used pre-recorded videos or website/mobile applications. Ninety-two percent (23/25) of programs provided an exercise prescription and resistance training, and 96% (24/25) provided aerobic training. Nearly one-quarter of respondents did not describe exercise progression. Seventy-four percent (17/23) of all programs provided exercise equipment, with 54% (7/13) VA programs using pedometers. Thirty-five percent (6/17) of outpatient hospital department sites conducted outcome assessments in-person only, 12% (2/17) conducted them virtually only, and 53% (9/17) provided both options, while 100% (5/5) commercial programs did so virtually. Six-minute walk test was the most common measure of exercise performance, used by 76% (13/17) outpatient hospital department sites and 20% (1/5) commercial programs. All VPR addresses were categorized as metropolitan or micropolitan; none were small town or rural.

Conclusions:
VPR in the U.S. is heterogeneous. Although most delivered the broad components of PR, there is lack of in-person assessments, in-person standardized exercise testing, and plans for exercise progression, most notably by commercial programs.

Rationale: Understanding virtual pulmonary rehabilitation (VPR) in the U.S. would inform clinicians and patients, guide healthcare systems to ensure quality and safety, and inform payers on reimbur...

AbstractBackgroundCOPD management is guided by the respiratory symptom burden, assessed using the modified Medical Resea...
10/03/2025

Abstract

Background
COPD management is guided by the respiratory symptom burden, assessed using the modified Medical Research Council (mMRC) scale, the COPD Assessment Test (CAT), or both.

Research Question
What are the abilities of mMRC and CAT to detect abnormally high exertional breathlessness on incremental cardiopulmonary cycle exercise testing (CPET) in people with COPD?

Study Design and Methods
Analysis of people aged ≥ 40 years with FEV1 to FVC ratio of < 0.70 after bronchodilator administration and ≥ 10 pack-years of smoking from the Canadian Cohort Obstructive Lung Disease study. Abnormal exertional breathlessness was defined as a breathlessness (Borg scale 0-10) intensity rating more than the upper limit of normal at the symptom-limited peak of CPET using normative reference equations.

Results
We included 318 people with COPD (40% female) with a mean (SD) age of 66.5 (9.3) years and FEV1 of 79.5% predicted (19.0% predicted); 26% showed abnormally low exercise capacity (peak oxygen uptake less than the lower limit of normal). Abnormally high exertional breathlessness was present in 24%, including 9% and 11% of people with mMRC score of 0 and CAT score of < 10, respectively. An mMRC score of ≥ 2 and CAT score of ≥ 10 was most specific (95%) to detect abnormal exertional breathlessness, but showed low sensitivity of only 12%. Accuracy for all scale cutoffs or combinations was < 65%. Compared with people with true-negatives findings, people with abnormal exertional breathlessness but low mMRC score, low CAT scores (false-negatives findings), or both showed worse self-reported and physiologic outcomes during CPET, were more likely to have physician-diagnosed COPD, but were not more likely to be taking any respiratory medication (37% vs 30%; mean difference, 6.1%; 95% CI, –7.2 to 19.4; P= .36).

Interpretation
In COPD, mMRC and CAT showed low concordance with CPET and failed to identify many people with abnormally high exertional breathlessness.

In COPD, mMRC and CAT showed low concordance with CPET and failed to identify many people with abnormally high exertional breathlessness.

Address

127 Λεωφόρος Βασιλίσσης Σοφίας
Athens
115 21

Alerts

Be the first to know and let us send you an email when Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Ελληνική Εταιρεία Εργοσπιρομετρίας, Άσκησης και Αποκατάστασης:

Share